Elucidating the Molecular Determinants of Aβ Aggregation with Deep Mutational Scanning. Issue 11 (1st November 2019)

• Record Type: Journal Article
• Authors: Gray, Vanessa E; Sitko, Katherine; Kameni, Floriane Z Ngako; Williamson, Miriam; Stephany, Jason J; Hasle, Nicholas; Fowler, Douglas M
• Is Part Of: G3. Volume 9:Issue 11(2019)
• Page Start: 3683
• Page End: 3689
• Publication Date: 2019-11-01
• Subjects: Amyloid -- Amyloid beta -- Deep mutational scanning -- Protein aggregation; Genetics -- Research -- Periodicals; Genomics -- Periodicals; Genetics; Genomics; Genes; Genetics -- Research; Genomics; Electronic journals; Periodical; Periodicals; Fulltext; Internet Resources; Periodicals; 572.8
• DOI: 10.1534/g3.119.400535
• Languages: English
• ISSNs: 2160-1836

Abstract

Abstract: Despite the importance of Aβ aggregation in Alzheimer's disease etiology, our understanding of the sequence determinants of aggregation is sparse and largely derived from in vitro studies. For example, in vitro proline and alanine scanning mutagenesis of Aβ40 proposed core regions important for aggregation. However, we lack even this limited mutagenesis data for the more disease-relevant Aβ42 . Thus, to better understand the molecular determinants of Aβ42 aggregation in a cell-based system, we combined a yeast DHFR aggregation assay with deep mutational scanning. We measured the effect of 791 of the 798 possible single amino acid substitutions on the aggregation propensity of Aβ42 . We found that ∼75% of substitutions, largely to hydrophobic residues, maintained or increased aggregation. We identified 11 positions at which substitutions, particularly to hydrophilic and charged amino acids, disrupted Aβ aggregation. These critical positions were similar but not identical to critical positions identified in previous Aβ mutagenesis studies. Finally, we analyzed our large-scale mutagenesis data in the context of different Aβ aggregate structural models, finding that the mutagenesis data agreed best with models derived from fibrils seeded using brain-derived Aβ aggregates.